With discovery of this new diagnosis method, Alzheimer's disease will soon be identified during its early stages.

As per recent reports, it has been revealed that a team of researchers at University of NSW have claimed that they are very close to development of blood test, which will help detect the disease at an early stage.

Psychiatry Professor Perminder Sachdev explained that in case of patients suffering from cognitive impairment, their apolipoproteins behave abnormally. Apolipoproteins are responsible for carrying cholesterol into the blood.

Further, it was explained that patients suffering from mild cognitive impairment finally develop the disease.

The researchers stated that they are on their ways to develop specific biomarkers, which can identify the people suffering from the condition; hence, they can be treated and further, do not develop Alzheimer's disease.

The research published in journal PLOS ONE, demonstrated that during the two-year study, blood samples of more than 1,000 volunteers were analyzed.

University of Newcastle senior researcher Pablo Moscato asserted that even he is working with the team for the development of this blood test.

Mr. Moscato affirmed: "I am working on developing a predictive blood test for Alzheimer's disease. Our team believes that the developed predictive blood test is between 85% and 90% accurate".